Health Canada requests additional time for review of SCENESSE® in EPP 2025 Announcements . Clinical . News . Regulatory 16.10.2025
Appendix 3H – Notification of cessation of securities 2025 Announcements . Financial . News . Regulatory 03.10.2025
Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 03.10.2025
Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 03.10.2025
CLINUVEL to advance novel pharmaceutical formulations in preclinical program 2025 Announcements . Clinical . News 29.09.2025
EMA approves year-round SCENESSE® treatment 2025 Announcements . Clinical . News . Regulatory 23.09.2025
SCENESSE® efficacy in vitiligo: new cases presented to EADV 2025 Announcements . Clinical . News 19.09.2025